News

As medications like Ozempic transform the health of millions of Americans, some families are discovering a surprising side ...
Tufts University scientists are aiming to revolutionize the future of weight loss drugs by engineering a new compound that ...
Despite incomplete evidence, longevity enthusiasts are experimenting with SGLT2 inhibitors in their quest to live healthier ...
Australia's Therapeutic Goods Administration (TGA) approved the weight-loss drug Mounjaro to treat sleep apnea, a condition ...
WEIGHT loss jabs could one day be dished out like statins, England’s top doctor says. Professor Sir Stephen Powis, medical ...
The FDA has granted approval to UGN-102 for use in patients with low-grade intermediate-risk non-muscle-invasive bladder ...
After decades of antipsychotic drugs, a new FDA-approved treatment for schizophrenia targets a different brain system—with ...
(THE CONVERSATION) On June 11, 2025, Health Secretary Robert F. Kennedy Jr. announced a slate of eight new members to serve ...
Taking inspiration from the CAR T-cell technology used to provide personalized cancer treatments, researchers have conducted ...
The number of people taking a popular party drug has skyrocketed, with doctors concerned that the epidemic is only getting ...
A final-stage clinical trial comparing a new long-acting, once-weekly pill to treat schizophrenia symptoms with the existing daily treatment has found that both produce comparable therapeutic effects.
A "Trojan horse" therapy that sneaks toxic drugs inside cancer cells is being made available on the NHS in England in a world ...